世界の解毒剤市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Antidote Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z0383 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：消費財

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、解毒剤のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（化学的解毒剤、物理的解毒剤、薬理学的解毒剤）、用途別市場規模（農薬中毒、重金属中毒、動物咬傷中毒、シアン化物中毒、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・解毒剤の市場動向 ・企業の競争状況、市場シェア ・解毒剤の種類別市場規模（化学的解毒剤、物理的解毒剤、薬理学的解毒剤） ・解毒剤の用途別市場規模（農薬中毒、重金属中毒、動物咬傷中毒、シアン化物中毒、その他） ・解毒剤の北米市場規模2016-2027（アメリカ、カナダ） ・解毒剤のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・解毒剤のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・解毒剤の中南米市場規模2016-2027（メキシコ、ブラジル） ・解毒剤の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Roche、Pfizer、Bayer、Johnson & Johnson、Novartis、Eli Lilly、Teva、Boehringer Ingelheim、Mylan、Fresenius Kabi、Baxter、Furen Pharmaceutical） ・結論

Antidote is agent that counters the effects of poison or over dosage by another drug. It helps in neutralizing the dangerous effects of a poison in body and has scientific approaches that have been taken to assess the therapeutic value of antidotes.
Antidote is on the rise all over the world, especially in North America, Europe, China, Japan and other countries.Moreover, antidotes are applied in many fields, among which pesticide poisoning is the field that applies the most antidotes, accounting for 27% of the market share.

Market Analysis and Insights: Global Antidote Market
The global Antidote market size is projected to reach US$ 10380 million by 2026, from US$ 8361.5 million in 2019, at a CAGR of 3.1% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Antidote market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Antidote market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Antidote market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Antidote market.

Global Antidote Scope and Market Size
Antidote market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Antidote market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Chemical Antidotes
Physical Antidotes
Pharmacological Antidotes

Segment by Application
Pesticide Poisoning
Heavy Metal Poisoning
Animal Bites Poisoning
Cyanide Poisoning
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Roche
Pfizer
Bayer
Johnson & Johnson
Novartis
Eli Lilly
Teva
Boehringer Ingelheim
Mylan
Johnson & Johnson

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antidote Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chemical Antidotes
1.2.3 Physical Antidotes
1.2.4 Pharmacological Antidotes
1.3 Market by Application
1.3.1 Global Antidote Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Pesticide Poisoning
1.3.3 Heavy Metal Poisoning
1.3.4 Animal Bites Poisoning
1.3.5 Cyanide Poisoning
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Antidote Market Perspective (2016-2027)
2.2 Antidote Growth Trends by Regions
2.2.1 Antidote Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Antidote Historic Market Share by Regions (2016-2021)
2.2.3 Antidote Forecasted Market Size by Regions (2022-2027)
2.3 Antidote Industry Dynamic
2.3.1 Antidote Market Trends
2.3.2 Antidote Market Drivers
2.3.3 Antidote Market Challenges
2.3.4 Antidote Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Antidote Players by Revenue
3.1.1 Global Top Antidote Players by Revenue (2016-2021)
3.1.2 Global Antidote Revenue Market Share by Players (2016-2021)
3.2 Global Antidote Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Antidote Revenue
3.4 Global Antidote Market Concentration Ratio
3.4.1 Global Antidote Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antidote Revenue in 2020
3.5 Antidote Key Players Head office and Area Served
3.6 Key Players Antidote Product Solution and Service
3.7 Date of Enter into Antidote Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Antidote Breakdown Data by Type
4.1 Global Antidote Historic Market Size by Type (2016-2021)
4.2 Global Antidote Forecasted Market Size by Type (2022-2027)

5 Antidote Breakdown Data by Application
5.1 Global Antidote Historic Market Size by Application (2016-2021)
5.2 Global Antidote Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Antidote Market Size (2016-2027)
6.2 North America Antidote Market Size by Type
6.2.1 North America Antidote Market Size by Type (2016-2021)
6.2.2 North America Antidote Market Size by Type (2022-2027)
6.2.3 North America Antidote Market Size by Type (2016-2027)
6.3 North America Antidote Market Size by Application
6.3.1 North America Antidote Market Size by Application (2016-2021)
6.3.2 North America Antidote Market Size by Application (2022-2027)
6.3.3 North America Antidote Market Size by Application (2016-2027)
6.4 North America Antidote Market Size by Country
6.4.1 North America Antidote Market Size by Country (2016-2021)
6.4.2 North America Antidote Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Antidote Market Size (2016-2027)
7.2 Europe Antidote Market Size by Type
7.2.1 Europe Antidote Market Size by Type (2016-2021)
7.2.2 Europe Antidote Market Size by Type (2022-2027)
7.2.3 Europe Antidote Market Size by Type (2016-2027)
7.3 Europe Antidote Market Size by Application
7.3.1 Europe Antidote Market Size by Application (2016-2021)
7.3.2 Europe Antidote Market Size by Application (2022-2027)
7.3.3 Europe Antidote Market Size by Application (2016-2027)
7.4 Europe Antidote Market Size by Country
7.4.1 Europe Antidote Market Size by Country (2016-2021)
7.4.2 Europe Antidote Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Antidote Market Size (2016-2027)
8.2 Asia-Pacific Antidote Market Size by Type
8.2.1 Asia-Pacific Antidote Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Antidote Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Antidote Market Size by Type (2016-2027)
8.3 Asia-Pacific Antidote Market Size by Application
8.3.1 Asia-Pacific Antidote Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Antidote Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Antidote Market Size by Application (2016-2027)
8.4 Asia-Pacific Antidote Market Size by Region
8.4.1 Asia-Pacific Antidote Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Antidote Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Antidote Market Size (2016-2027)
9.2 Latin America Antidote Market Size by Type
9.2.1 Latin America Antidote Market Size by Type (2016-2021)
9.2.2 Latin America Antidote Market Size by Type (2022-2027)
9.2.3 Latin America Antidote Market Size by Type (2016-2027)
9.3 Latin America Antidote Market Size by Application
9.3.1 Latin America Antidote Market Size by Application (2016-2021)
9.3.2 Latin America Antidote Market Size by Application (2022-2027)
9.3.3 Latin America Antidote Market Size by Application (2016-2027)
9.4 Latin America Antidote Market Size by Country
9.4.1 Latin America Antidote Market Size by Country (2016-2021)
9.4.2 Latin America Antidote Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Antidote Market Size (2016-2027)
10.2 Middle East & Africa Antidote Market Size by Type
10.2.1 Middle East & Africa Antidote Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Antidote Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Antidote Market Size by Type (2016-2027)
10.3 Middle East & Africa Antidote Market Size by Application
10.3.1 Middle East & Africa Antidote Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Antidote Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Antidote Market Size by Application (2016-2027)
10.4 Middle East & Africa Antidote Market Size by Country
10.4.1 Middle East & Africa Antidote Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Antidote Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Antidote Introduction
11.1.4 Roche Revenue in Antidote Business (2016-2021)
11.1.5 Roche Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Antidote Introduction
11.2.4 Pfizer Revenue in Antidote Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 Bayer
11.3.1 Bayer Company Details
11.3.2 Bayer Business Overview
11.3.3 Bayer Antidote Introduction
11.3.4 Bayer Revenue in Antidote Business (2016-2021)
11.3.5 Bayer Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Antidote Introduction
11.4.4 Johnson & Johnson Revenue in Antidote Business (2016-2021)
11.4.5 Johnson & Johnson Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Antidote Introduction
11.5.4 Novartis Revenue in Antidote Business (2016-2021)
11.5.5 Novartis Recent Development
11.6 Eli Lilly
11.6.1 Eli Lilly Company Details
11.6.2 Eli Lilly Business Overview
11.6.3 Eli Lilly Antidote Introduction
11.6.4 Eli Lilly Revenue in Antidote Business (2016-2021)
11.6.5 Eli Lilly Recent Development
11.7 Teva
11.7.1 Teva Company Details
11.7.2 Teva Business Overview
11.7.3 Teva Antidote Introduction
11.7.4 Teva Revenue in Antidote Business (2016-2021)
11.7.5 Teva Recent Development
11.8 Boehringer Ingelheim
11.8.1 Boehringer Ingelheim Company Details
11.8.2 Boehringer Ingelheim Business Overview
11.8.3 Boehringer Ingelheim Antidote Introduction
11.8.4 Boehringer Ingelheim Revenue in Antidote Business (2016-2021)
11.8.5 Boehringer Ingelheim Recent Development
11.9 Mylan
11.9.1 Mylan Company Details
11.9.2 Mylan Business Overview
11.9.3 Mylan Antidote Introduction
11.9.4 Mylan Revenue in Antidote Business (2016-2021)
11.9.5 Mylan Recent Development
11.10 Fresenius Kabi
11.10.1 Fresenius Kabi Company Details
11.10.2 Fresenius Kabi Business Overview
11.10.3 Fresenius Kabi Antidote Introduction
11.10.4 Fresenius Kabi Revenue in Antidote Business (2016-2021)
11.10.5 Fresenius Kabi Recent Development
11.11 Baxter
11.11.1 Baxter Company Details
11.11.2 Baxter Business Overview
11.11.3 Baxter Antidote Introduction
11.11.4 Baxter Revenue in Antidote Business (2016-2021)
11.11.5 Baxter Recent Development
11.12 Furen Pharmaceutical
11.12.1 Furen Pharmaceutical Company Details
11.12.2 Furen Pharmaceutical Business Overview
11.12.3 Furen Pharmaceutical Antidote Introduction
11.12.4 Furen Pharmaceutical Revenue in Antidote Business (2016-2021)
11.12.5 Furen Pharmaceutical Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Antidote Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chemical Antidotes
Table 3. Key Players of Physical Antidotes
Table 4. Key Players of Pharmacological Antidotes
Table 5. Global Antidote Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Antidote Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Antidote Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Antidote Market Share by Regions (2016-2021)
Table 9. Global Antidote Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Antidote Market Share by Regions (2022-2027)
Table 11. Antidote Market Trends
Table 12. Antidote Market Drivers
Table 13. Antidote Market Challenges
Table 14. Antidote Market Restraints
Table 15. Global Antidote Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Antidote Market Share by Players (2016-2021)
Table 17. Global Top Antidote Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antidote as of 2020)
Table 18. Ranking of Global Top Antidote Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Antidote Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Antidote Product Solution and Service
Table 22. Date of Enter into Antidote Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Antidote Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Antidote Revenue Market Share by Type (2016-2021)
Table 26. Global Antidote Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Antidote Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Antidote Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Antidote Revenue Market Share by Application (2016-2021)
Table 30. Global Antidote Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Antidote Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Antidote Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Antidote Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Antidote Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Antidote Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Antidote Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Antidote Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Antidote Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Antidote Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Antidote Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Antidote Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Antidote Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Antidote Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Antidote Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Antidote Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Antidote Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Antidote Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Antidote Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Antidote Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Antidote Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Antidote Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Antidote Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Antidote Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Antidote Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Antidote Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Antidote Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Antidote Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Antidote Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Antidote Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Antidote Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Antidote Market Size by Country (2022-2027) & (US$ Million)
Table 62. Roche Company Details
Table 63. Roche Business Overview
Table 64. Roche Antidote Product
Table 65. Roche Revenue in Antidote Business (2016-2021) & (US$ Million)
Table 66. Roche Recent Development
Table 67. Pfizer Company Details
Table 68. Pfizer Business Overview
Table 69. Pfizer Antidote Product
Table 70. Pfizer Revenue in Antidote Business (2016-2021) & (US$ Million)
Table 71. Pfizer Recent Development
Table 72. Bayer Company Details
Table 73. Bayer Business Overview
Table 74. Bayer Antidote Product
Table 75. Bayer Revenue in Antidote Business (2016-2021) & (US$ Million)
Table 76. Bayer Recent Development
Table 77. Johnson & Johnson Company Details
Table 78. Johnson & Johnson Business Overview
Table 79. Johnson & Johnson Antidote Product
Table 80. Johnson & Johnson Revenue in Antidote Business (2016-2021) & (US$ Million)
Table 81. Johnson & Johnson Recent Development
Table 82. Novartis Company Details
Table 83. Novartis Business Overview
Table 84. Novartis Antidote Product
Table 85. Novartis Revenue in Antidote Business (2016-2021) & (US$ Million)
Table 86. Novartis Recent Development
Table 87. Eli Lilly Company Details
Table 88. Eli Lilly Business Overview
Table 89. Eli Lilly Antidote Product
Table 90. Eli Lilly Revenue in Antidote Business (2016-2021) & (US$ Million)
Table 91. Eli Lilly Recent Development
Table 92. Teva Company Details
Table 93. Teva Business Overview
Table 94. Teva Antidote Product
Table 95. Teva Revenue in Antidote Business (2016-2021) & (US$ Million)
Table 96. Teva Recent Development
Table 97. Boehringer Ingelheim Company Details
Table 98. Boehringer Ingelheim Business Overview
Table 99. Boehringer Ingelheim Revenue in Antidote Business (2016-2021) & (US$ Million)
Table 100. Boehringer Ingelheim Recent Development
Table 101. Mylan Company Details
Table 102. Mylan Business Overview
Table 103. Mylan Antidote Product
Table 104. Mylan Revenue in Antidote Business (2016-2021) & (US$ Million)
Table 105. Mylan Recent Development
Table 106. Fresenius Kabi Company Details
Table 107. Fresenius Kabi Business Overview
Table 108. Fresenius Kabi Antidote Product
Table 109. Fresenius Kabi Revenue in Antidote Business (2016-2021) & (US$ Million)
Table 110. Fresenius Kabi Recent Development
Table 111. Baxter Company Details
Table 112. Baxter Business Overview
Table 113. Baxter Antidote Product
Table 114. Baxter Revenue in Antidote Business (2016-2021) & (US$ Million)
Table 115. Baxter Recent Development
Table 116. Furen Pharmaceutical Company Details
Table 117. Furen Pharmaceutical Business Overview
Table 118. Furen Pharmaceutical Antidote Product
Table 119. Furen Pharmaceutical Revenue in Antidote Business (2016-2021) & (US$ Million)
Table 120. Furen Pharmaceutical Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antidote Market Share by Type: 2020 VS 2027
Figure 2. Chemical Antidotes Features
Figure 3. Physical Antidotes Features
Figure 4. Pharmacological Antidotes Features
Figure 5. Global Antidote Market Share by Application: 2020 VS 2027
Figure 6. Pesticide Poisoning Case Studies
Figure 7. Heavy Metal Poisoning Case Studies
Figure 8. Animal Bites Poisoning Case Studies
Figure 9. Cyanide Poisoning Case Studies
Figure 10. Others Case Studies
Figure 11. Antidote Report Years Considered
Figure 12. Global Antidote Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Antidote Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Antidote Market Share by Regions: 2020 VS 2027
Figure 15. Global Antidote Market Share by Regions (2022-2027)
Figure 16. Global Antidote Market Share by Players in 2020
Figure 17. Global Top Antidote Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antidote as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Antidote Revenue in 2020
Figure 19. Global Antidote Revenue Market Share by Type (2016-2021)
Figure 20. Global Antidote Revenue Market Share by Type (2022-2027)
Figure 21. North America Antidote Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Antidote Market Share by Type (2016-2027)
Figure 23. North America Antidote Market Share by Application (2016-2027)
Figure 24. North America Antidote Market Share by Country (2016-2027)
Figure 25. United States Antidote Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Antidote Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Antidote Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Antidote Market Share by Type (2016-2027)
Figure 29. Europe Antidote Market Share by Application (2016-2027)
Figure 30. Europe Antidote Market Share by Country (2016-2027)
Figure 31. Germany Antidote Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Antidote Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Antidote Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Antidote Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Antidote Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Antidote Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Antidote Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Antidote Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Antidote Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Antidote Market Share by Region (2016-2027)
Figure 41. China Antidote Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Antidote Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Antidote Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Antidote Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Antidote Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Antidote Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Antidote Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Antidote Market Share by Type (2016-2027)
Figure 49. Latin America Antidote Market Share by Application (2016-2027)
Figure 50. Latin America Antidote Market Share by Country (2016-2027)
Figure 51. Mexico Antidote Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Antidote Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Antidote Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Antidote Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Antidote Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Antidote Market Share by Country (2016-2027)
Figure 57. Turkey Antidote Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Antidote Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Antidote Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Roche Revenue Growth Rate in Antidote Business (2016-2021)
Figure 61. Pfizer Revenue Growth Rate in Antidote Business (2016-2021)
Figure 62. Bayer Revenue Growth Rate in Antidote Business (2016-2021)
Figure 63. Johnson & Johnson Revenue Growth Rate in Antidote Business (2016-2021)
Figure 64. Novartis Revenue Growth Rate in Antidote Business (2016-2021)
Figure 65. Eli Lilly Revenue Growth Rate in Antidote Business (2016-2021)
Figure 66. Teva Revenue Growth Rate in Antidote Business (2016-2021)
Figure 67. Boehringer Ingelheim Revenue Growth Rate in Antidote Business (2016-2021)
Figure 68. Mylan Revenue Growth Rate in Antidote Business (2016-2021)
Figure 69. Fresenius Kabi Revenue Growth Rate in Antidote Business (2016-2021)
Figure 70. Baxter Revenue Growth Rate in Antidote Business (2016-2021)
Figure 71. Furen Pharmaceutical Revenue Growth Rate in Antidote Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

---